EP2167067A1 - USE OF EFLUCIMIBE FOR THE PRODUCTION OF A MEDICAMENT FOR THE PREVENTION OR TREATMENT OF A DISEASE CAUSED BY SEBACEOUS GLAND DYSFUNCTION IN HUMANS OR ANIMALS